Jan 12 (Reuters) - Lantern Pharma Inc LTRN.O:
LANTERN PHARMA INC - ESTABLISHES AI CENTER OF EXCELLENCE IN BENGALURU
LANTERN PHARMA INC - HIRING INITIATED, EXPANSION EXPECTED TO BE CASH FLOW NEUTRAL
LANTERN PHARMA INC - PHASE 1 FOCUSES ON AI-DRIVEN CANCER DRUG DEVELOPMENT
LANTERN PHARMA INC - PHASE 2 FOCUSES ON MULTI-DISEASE EXPANSION AND REVENUE ACCELERATION
Source text: ID:nBw1lXc0xa
Further company coverage: LTRN.O
((Reuters.Briefs@thomsonreuters.com;))